158 related articles for article (PubMed ID: 34817796)
1. Genetic modulation of longitudinal change in neurocognitive function among adult glioma patients.
Wefel JS; Zhou R; Sulman EP; Boehling NS; Armstrong GN; Tsavachidis S; Liang FW; Etzel CJ; Kahalley LS; Small BJ; Scheurer ME; Bondy ML; Liu Y
J Neurooncol; 2022 Jan; 156(1):185-193. PubMed ID: 34817796
[TBL] [Abstract][Full Text] [Related]
2. Genetic Modulation of Neurocognitive Function in Glioma Patients.
Liu Y; Zhou R; Sulman EP; Scheurer ME; Boehling N; Armstrong GN; Tsavachidis S; Liang FW; Etzel CJ; Conrad CA; Gilbert MR; Armstrong TS; Bondy ML; Wefel JS
Clin Cancer Res; 2015 Jul; 21(14):3340-6. PubMed ID: 25904748
[TBL] [Abstract][Full Text] [Related]
3. Neurocognitive changes after awake surgery in glioma patients: a retrospective cohort study.
van Kessel E; Snijders TJ; Baumfalk AE; Ruis C; van Baarsen KM; Broekman ML; van Zandvoort MJE; Robe PA
J Neurooncol; 2020 Jan; 146(1):97-109. PubMed ID: 31802314
[TBL] [Abstract][Full Text] [Related]
4. Neurocognitive function varies by IDH1 genetic mutation status in patients with malignant glioma prior to surgical resection.
Wefel JS; Noll KR; Rao G; Cahill DP
Neuro Oncol; 2016 Dec; 18(12):1656-1663. PubMed ID: 27576872
[TBL] [Abstract][Full Text] [Related]
5. Alterations in Functional Connectomics Associated With Neurocognitive Changes Following Glioma Resection.
Noll KR; Chen HS; Wefel JS; Kumar VA; Hou P; Ferguson SD; Rao G; Johnson JM; Schomer DF; Suki D; Prabhu SS; Liu HL
Neurosurgery; 2021 Feb; 88(3):544-551. PubMed ID: 33080024
[TBL] [Abstract][Full Text] [Related]
6. Neurocognitive Changes Associated With Surgical Resection of Left and Right Temporal Lobe Glioma.
Noll KR; Weinberg JS; Ziu M; Benveniste RJ; Suki D; Wefel JS
Neurosurgery; 2015 Nov; 77(5):777-85. PubMed ID: 26317672
[TBL] [Abstract][Full Text] [Related]
7. Relationships between tumor grade and neurocognitive functioning in patients with glioma of the left temporal lobe prior to surgical resection.
Noll KR; Sullaway C; Ziu M; Weinberg JS; Wefel JS
Neuro Oncol; 2015 Apr; 17(4):580-7. PubMed ID: 25227126
[TBL] [Abstract][Full Text] [Related]
8. Association between tumor location and neurocognitive functioning using tumor localization maps.
Habets EJJ; Hendriks EJ; Taphoorn MJB; Douw L; Zwinderman AH; Vandertop WP; Barkhof F; De Witt Hamer PC; Klein M
J Neurooncol; 2019 Sep; 144(3):573-582. PubMed ID: 31410731
[TBL] [Abstract][Full Text] [Related]
9. Tumor-related neurocognitive dysfunction in patients with diffuse glioma: a systematic review of neurocognitive functioning prior to anti-tumor treatment.
van Kessel E; Baumfalk AE; van Zandvoort MJE; Robe PA; Snijders TJ
J Neurooncol; 2017 Aug; 134(1):9-18. PubMed ID: 28567586
[TBL] [Abstract][Full Text] [Related]
10. Association between objective neurocognitive functioning and neurocognitive complaints in recurrent high-grade glioma: Longitudinal evidence of cognitive awareness from EORTC brain tumour trials.
Caramanna I; Reijneveld JC; van de Ven PM; van den Bent M; Idbaih A; Wick W; Taphoorn MJB; Dirven L; Bottomley A; Klein M;
Eur J Cancer; 2023 Jun; 186():38-51. PubMed ID: 37028200
[TBL] [Abstract][Full Text] [Related]
11. Tumor-related neurocognitive dysfunction in patients with diffuse glioma: a retrospective cohort study prior to antitumor treatment.
van Kessel E; Emons MAC; Wajer IH; van Baarsen KM; Broekman ML; Robe PA; Snijders TJ; Van Zandvoort MJE
Neurooncol Pract; 2019 Dec; 6(6):463-472. PubMed ID: 31832216
[TBL] [Abstract][Full Text] [Related]
12. Quality of Life Is Independently Associated With Neurocognitive Function in Patients With Brain Tumors: Analysis of a Prospective Clinical Trial.
Salans M; Tibbs MD; Huynh-Le MP; Yip A; Tringale K; Karunamuni R; Xu R; Reyes A; Macari AC; Pan-Weisz T; McDonald CR; Hattangadi-Gluth JA
Int J Radiat Oncol Biol Phys; 2021 Nov; 111(3):754-763. PubMed ID: 34102297
[TBL] [Abstract][Full Text] [Related]
13. Pre-operative Neurocognitive Function Was More Susceptible to Decline in Isocitrate Dehydrogenase Wild-Type Subgroups of Lower-Grade Glioma Patients.
Zhang Z; Jin Z; Yang X; Zhang L; Zhang Y; Liu D; Chi X; Hao S; Feng J; Ji N
Front Neurol; 2020; 11():591615. PubMed ID: 33363506
[No Abstract] [Full Text] [Related]
14. Genetic variants in telomerase-related genes are associated with an older age at diagnosis in glioma patients: evidence for distinct pathways of gliomagenesis.
Walsh KM; Rice T; Decker PA; Kosel ML; Kollmeyer T; Hansen HM; Zheng S; McCoy LS; Bracci PM; Anderson E; Hsuang G; Wiemels JL; Pico AR; Smirnov I; Molinaro AM; Tihan T; Berger MS; Chang SM; Prados MD; Lachance DH; Sicotte H; Eckel-Passow JE; Wiencke JK; Jenkins RB; Wrensch MR
Neuro Oncol; 2013 Aug; 15(8):1041-7. PubMed ID: 23733245
[TBL] [Abstract][Full Text] [Related]
15. Objective neurocognitive functioning and neurocognitive complaints in patients with high-grade glioma: Evidence of cognitive awareness from the European Organisation for Research and Treatment of Cancer brain tumour clinical trials.
Caramanna I; Bottomley A; Drijver AJ; Twisk J; van den Bent M; Idbaih A; Wick W; Pe M; Klein M; Reijneveld JC;
Eur J Cancer; 2021 Feb; 144():162-168. PubMed ID: 33348088
[TBL] [Abstract][Full Text] [Related]
16. Relationships between neurocognitive functioning, mood, and quality of life in patients with temporal lobe glioma.
Noll KR; Bradshaw ME; Weinberg JS; Wefel JS
Psychooncology; 2017 May; 26(5):617-624. PubMed ID: 26677053
[TBL] [Abstract][Full Text] [Related]
17. Neurocognitive functioning in patients with glioma of the left and right temporal lobes.
Noll KR; Ziu M; Weinberg JS; Wefel JS
J Neurooncol; 2016 Jun; 128(2):323-31. PubMed ID: 27022915
[TBL] [Abstract][Full Text] [Related]
18. Impaired neurocognitive function in glioma patients: from pathophysiology to novel intervention strategies.
Noll KR; Walbert T; Wefel JS
Curr Opin Neurol; 2020 Dec; 33(6):716-722. PubMed ID: 33009006
[TBL] [Abstract][Full Text] [Related]
19. Cognitive and radiological effects of radiotherapy in patients with low-grade glioma: long-term follow-up.
Douw L; Klein M; Fagel SS; van den Heuvel J; Taphoorn MJ; Aaronson NK; Postma TJ; Vandertop WP; Mooij JJ; Boerman RH; Beute GN; Sluimer JD; Slotman BJ; Reijneveld JC; Heimans JJ
Lancet Neurol; 2009 Sep; 8(9):810-8. PubMed ID: 19665931
[TBL] [Abstract][Full Text] [Related]
20. Tumor-related molecular determinants of neurocognitive deficits in patients with diffuse glioma.
van Kessel E; Berendsen S; Baumfalk AE; Venugopal H; Krijnen EA; Spliet WGM; van Hecke W; Giuliani F; Seute T; van Zandvoort MJE; Snijders TJ; Robe PA
Neuro Oncol; 2022 Oct; 24(10):1660-1670. PubMed ID: 35148403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
